NovoCure (NVCR) Stock Price, Quote, News & History | Benzinga

NovoCure Ltd (NVCR) Stock Price, Quote, News & History

NVCRNASDAQ

Trade with Public

Trade with Public

$18.20

At close: Aug 20, 5:00 PM EST

$18.25

0.050.27%

After Hours: 7:54 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 1.67M

Day Range

- - -

52 Wk Range

9.82 - 21.45

Market Cap

$2.13B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

64

Short Interest

11.77%

Days to Cover

4.89

Recent NovoCure Limited News

NovoCure's Strongest Quarter Ever Isn't Enough to Stop NVCR Stock From Sliding

NovoCure revenue outlook rises after a Q2 beat, stronger patient growth, pipeline progress and planned trial savings.

Akanksha Bakshi

Crude Oil Rises Sharply; T-Mobile Shares Fall Following Q2 Results

US stocks lower, Dow down 0.92%, NASDAQ 2.03% decline. T-Mobile stock falls 5%. NVE Corp up 38%, Novocure up 25%, Cleveland-Cliffs up 19%

Avi Kapoor

Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursday

U.S. stocks were down as Dow Jones fell 450 points on Thursday. Lockheed Martin (LMT) shares rose 11.4% on better-than-expected results. Other big gainers were NVE Corp (NVEC), Gibo Holdings Ltd (GIBO), Novocure Ltd (NVCR), Cleveland-Cliffs Inc (CLF), Merlin Inc (MRLN), Medpace Holdings Inc (MEDP), Oatly Group AB (OTLY), Imax Corp (IMAX), United Rentals Inc (URI), Oceaneering International Inc (OII), and Quest Diagnostics Inc (DGX).

Avi Kapoor

Crude Oil Down 2%; Accenture Shares Fall After Q3 Results

U.S. stocks traded higher on Thursday with the S&P 500 gaining 1% while tech shares surged 2.3%. Accenture stock tumbled 15% after weaker outlook.

Avi Kapoor

Novocure Brain Cancer Study Shows No Significant Survival Benefit, Stock Tanks

Novocure's Phase 3 TRIDENT trial missed its primary survival endpoint in glioblastoma but confirmed TTFields safety.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-2.82M

Investing Cash Flow (TTM)

409.13M

Financing Cash Flow (TTM)

-454.60M

Free Cash Flow (TTM)

-25.43M

Capital Expenditure (TTM)

-22.62M

Net Change in Cash (TTM)

-48.28M

Analyst Trends and Forecast

1

Feb

1

Apr

1

1

May

1

Jun

1

2

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.91B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.96

PB Ratio (TTM)

6.27

Earnings Yield % (TTM)

-7.14%

Earnings Yield % (FWD)

-4.34%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.90

Company Debt

Total Debt

$195.89M

LT Debt

$195.89M

LT Debt Issuance (TTM)

$99.98M

LT Debt Repayment (TTM)

-$560.95M

Total Cash

$93.70M

Debt to Equity

0.69

Issuance of Debt (TTM)

-$460.97M

Repayment of Debt (TTM)

-$560.95M

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 1.67M

Day Range

- - -

52 Wk Range

9.82 - 21.45

Market Cap

$2.13B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

64

Short Interest

11.77%

Days to Cover

4.89

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lu...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy NovoCure (NVCR) stock?

A

You can purchase shares of NovoCure (NASDAQ:NVCR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are NovoCure (NVCR) competitors?

A

Other companies in NovoCure’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Stryker Corp (NYSE:SYK), Medtronic PLC (NYSE:MDT) and Boston Scientific Corp (NYSE:BSX).

Q

What is the forecast, or price target, for NovoCure (NVCR) stock?

A

NovoCure has a consensus price target of $27.14.

Q

What is the current price for NovoCure (NVCR)?

A

The stock price for NovoCure (NASDAQ: NVCR) is $18.25 last updated August 19, 2026 at 7:54 PM EDT.

Q

Does NovoCure (NVCR) pay a dividend?

A

There are no upcoming dividends for NovoCure.

Q

When is NovoCure (NASDAQ:NVCR) reporting earnings?

A

NovoCure does not have any upcoming earnings scheduled.

Q

Is NovoCure (NVCR) going to split?

A

There is no upcoming split for NovoCure.

Q

What sector and industry does NovoCure (NVCR) operate in?

A

NovoCure is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.